Cited by 584Prion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease.

Open access
Cunningham, Colm, Campion, Suzanne, Lunnon, Katie, Murray, Carol L., Woods, Jack F.C., Deacon, Robert M.J., Rawlins, J. Nicholas P., Perry, V. Hugh·2009·Biological Psychiatry

Abstract

BACKGROUND: Chronic neurodegeneration results in microglial activation, but the contribution of inflammation to the progress of neurodegeneration remains unclear. We have shown that microglia express low levels of proinflammatory cytokines during chronic neurodegeneration but are "primed" to produce a more proinflammatory profile after systemic challenge with bacterial endotoxin (lipopolysaccharide [LPS]). METHODS: Here, we investigated whether intraperitoneal (IP) challenge with LPS, to mimic systemic infection, in the early stages of prion disease can 1) produce exaggerated acute behavioral (n = 9) and central nervous system (CNS) inflammatory (n = 4) responses in diseased animals compared with control animals, and 2) whether a single LPS challenge can accelerate disease progression (n = 34-35). RESULTS: Injection of LPS (100 microg/kg), at 12 weeks postinoculation (PI), resulted in heightened CNS interleukin-1 beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha), and interferon-beta (IFN-beta) transcription and microglial IL-1beta translation in prion-diseased animals relative to control animals. This inflammation caused exaggerated impairments in burrowing and locomotor activity, and induced hypothermia and cognitive changes in prion-diseased animals that were absent in LPS-treated control animals. At 15 weeks PI, LPS (500 microg/kg) acutely impaired motor coordination and muscle strength in prion-diseased but not in control animals. After recovery, these animals also showed earlier onset of disease-associated impairments on these parameters. CONCLUSIONS: These data demonstrate that transient systemic inflammation superimposed on neurodegenerative disease acutely exacerbates cognitive and motor symptoms of disease and accelerates disease progression. These deleterious effects of systemic inflammation have implications for the treatment of chronic neurodegeneration and associated delirium.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2008.07.024

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Macrophages are one of the main producers of inflammatory cytokines.

    “macrophages are known to be one of the main producers of inflammatory cytokines”

    From Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner (2024) · cites this paper as [2]

    The Discussion (Exaggerated Sickness Behavior and Microglial Priming; page unavailable) reports IL-1β production by hippocampal microglia after systemic LPS challenge. The paper does not establish that macrophages generally are among the main producers of inflammatory cytokines; its finding concerns microglia under a specific condition. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Chronic inflammatory cytokines can exacerbate neurodegeneration.

    “which, when chronic, can exacerbate neurodegeneration [2–4]”

    From Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner (2024) · cites this paper as [2]

    The Abstract Conclusions report that transient systemic inflammation accelerates neurodegenerative disease, and the Discussion Conclusion cites evidence that systemic IL-1β exacerbates neurodegeneration. Neither passage establishes that chronic exposure to inflammatory cytokines causes the exacerbation; the paper says its mechanism remains unclear. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Animal studies demonstrated that systemic immune activation by viral, bacterial, or parasitic infections results in impaired memory functioning.

    “Studies in experimental animals demonstrated that systemic immune activation by viral, bacterial, or parasitic infections result in impaired memory functioning [18], [19], [20], [21], [22], [23].”
  • Systemic endotoxin precipitates brain pathology in mice expressing prions, APP variants or TAU variants or mice with α-synuclein injected in the brain.

    “and systemic endotoxin precipitates brain pathology in mice expressing prions [74], APP variants [33] or TAU variants [69] or mice with α-synuclein injected in the brain [46].”

    From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [74]

  • A series of studies using a ME7 prion disease model showed dystrophic morphology of microglia and enhanced expression of inflammatory mediators such as IL-1β and COX-2 following in vivo LPS challenge; the exaggerated inflammatory changes in ME7 mice were also associated with impairments in spatial learning.

    “A series of studies using a ME7 prion disease model showed dystrophic morphology of microglia and enhanced expression of inflammatory mediators such as IL-1β and COX-2 following in vivo LPS challenge.The exaggerated inflammatory changes in ME7 mice were also associated with impairments in spatial learning (Cunningham et al, 2009).”

    From Microglia Priming with Aging and Stress (2017) · cites this paper as Cunningham et al, 2009

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cunningham, C., Campion, S., Lunnon, K., Murray, C. L., Woods, J. F. C., Deacon, R. M. J., Rawlins, J. N. P., & Perry, V. H.
Affiliations
  • Trinity College Dublin (IE)
  • University of Southampton (GB)
  • University of Oxford (GB)
Corresponding author
Cunningham, Colm
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2009-02
Volume
65
Issue
4
Pages
304-312
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2093984890
Cited by
584
References
55
Citations by year
2026: 18 · 2025: 24 · 2024: 40 · 2023: 22 · 2022: 33 · 2021: 50 · 2020: 33 · 2019: 32 · 2018: 28 · 2017: 40 · 2016: 38 · 2015: 38 · 2014: 40 · 2013: 43 · 2012: 35
FWCI
9.33
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Open Research Exeter (University of Exeter) (publishedVersion, cc-by)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • Figshare (submittedVersion)
Funders
Wellcome Trust
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
systemic inflammation, lipopolysaccharide, prion disease, neurodegeneration, microglial activation, IL-1β, TNF-α, interferon-beta, cognitive impairment, motor coordination, disease progression, behavior change, hypothermia, delirium
MeSH terms
Animals, Behavior, Animal, Body Temperature, Cognition, Female, Immunohistochemistry, Inflammation, Infusions, Parenteral, Lipopolysaccharides, Longitudinal Studies, Mice, Inbred C57BL, Motor Activity, Psychomotor Performance, Maze Learning, Neurodegenerative Diseases, Reverse Transcriptase Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review